CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 97 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $845,714 | -49.2% | 26,813 | -54.5% | 0.00% | -50.0% |
| Q3 2022 | $1,665,000 | +71.3% | 58,934 | +60.3% | 0.00% | +100.0% |
| Q2 2022 | $972,000 | -70.7% | 36,759 | -61.2% | 0.00% | -66.7% |
| Q1 2022 | $3,317,000 | -4.4% | 94,752 | -11.5% | 0.00% | 0.0% |
| Q4 2021 | $3,470,000 | +126.2% | 107,026 | +105.8% | 0.00% | +50.0% |
| Q3 2021 | $1,534,000 | – | 51,997 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |